Empagliflozin in Patients With Cirrhosis and Ascites

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Empagliflozin in Patients With Cirrhosis and Ascites	Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, liver failure	Recruiting	Phase 2	2026-09-14		NCT05726032

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boehringer Ingelheim	158
Yale University	458

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Yale University	New Haven	United States	76

Clinical trials